rAd-IFN/Syn3

· FKD Therapies Oy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rAd-IFN/Syn3, covering 2017-05-30 to 2017-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer [Phase 2]